What if your own immune cells could be engineered to fight and even cure cancer?In this episode of Rx for Biotech, host Chris Leidli sits down with Navneet Majhail, MD, a leading expert in blood cancers, bone marrow transplants, and CAR-T cell therapy, to break down one of the most powerful innovations in modern medicine: CAR-T therapy.CAR-T therapy is a form of immunotherapy that uses a patient’s own T cells - engineered in a lab - to recognize and destroy cancer. It has already transformed outcomes for patients with leukemia, lymphoma, and multiple myeloma, offering hope where few options previously existed.But despite its promise, many eligible patients still don’t receive CAR-T therapy due to barriers like access, geography, insurance, and care coordination.In this conversation, Dr. Majhail explains:• What CAR-T cell therapy is and how it works• Why access to treatment remains a major challenge• The role of bone marrow transplant and cellular therapy networks• How care is shifting closer to home through community-based treatment models• The importance of caregivers and support systems during treatment• What the future holds for CAR-T in solid tumors, autoimmune diseases, and beyondThis episode is a must-watch for patients, caregivers, and anyone interested in the future of personalized cancer treatment, immunotherapy, and advanced therapies